Nalaganje...
Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy
PURPOSE: Immunotherapy has become the standard treatment for advanced tumors so that many biomarkers play parts in predicting prognosis and clinical outcome. Use of FARI is increasing, but there are no studies on its use prior to immunotherapy. PATIENTS AND METHODS: A retrospective study prior to im...
Shranjeno v:
| izdano v: | Cancer Manag Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8163584/ https://ncbi.nlm.nih.gov/pubmed/34079370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S307272 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|